Live With Lumere: 30 Minutes With Lumere Experts on Strategic Sourcing & Coronary Stents Reserve Your Spot
Get Started Sign In

Lumere’s CEO Hani Elias, JD, MPH, will speak alongside Amy Whitaker of Bon Secours Mercy Health in a breakout session on September 11. Register to attend here.

Expediting Mergers & Acquisitions: The Role of Data and Clinical Evidence (Strategy, Financial; Course Level-Intermediate)

  • Hani Elias, JD, MPH – Chief Executive Officer, Lumere
  • Amy Whitaker, RN – Vice President, Supply Chain Clinical Integration Accountability, Bon Secours Mercy Health

The healthcare industry has experienced a frenzy of merger and acquisition (M&A) activity in recent years which continues to remain steady. While mergers come with the promise of eliminating inefficiencies and benefiting from scale, the path is often complex. In fact, research has shown that hospitals often fail to realize cost synergies. Bon Secours and Mercy Health were committed to producing a different result.

Attend this session to learn how these organizations jointly leveraged clinical evidence and analytics to accelerate the benefits of their merger. To do so, they built an organizational framework to quickly scale and align their value analysis and vendor management capabilities. The result has been astounding, identifying savings of more than $48.9M in supply-related costs and achieving standardization in several clinical practices in less than two years.

Learn from these two presenters with a diverse range of clinical and operational experience. Amy Whitaker, RN, is the Vice President of Supply Chain Clinical Integration Accountability for all clinical integration activities within the organization while Hani Elias, JD, MPH, CEO of Lumere, provides strategic vision and advises health system executives on how to achieve the best clinical outcomes at an optimal cost.